PGNY News and Press, Progyny Inc. From 12/14/22

Summary Progyny is the only fertility company to gather and publish data about treatment outcomes, which leads to better clinical results compared to the competition. Progyny's superior solutions enable the company to develop a strong brand awareness as it is demonstrated by the company...

Progyny Inc. ( NASDAQ: PGNY ) dropped 7% after a new short report from Jehoshaphat Research on the fertility company. Jehoshaphat said it's short shares of Progyny ( PGNY ). Progyny ( PGNY ) didn't immediately return Seeking Alpha email request for comment. Pr...

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that it is raising its financial guidanc...

Summary Shares of Progyny have caught a bid in recent months as investors seek out quality cash earners. The trade looks exhausted, however, and a combination of factors suggest recent downside in the PGNY share price is warranted. Shares looked to be fairly priced at $16.90, ...

NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...

Progyny, Inc. (PGNY) Q3 2022 Earnings Conference Call November 03, 2022 04:45 PM ET Company Participants James Hart - VP, IR Peter Anevski - CEO Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Sec...

Progyny press release ( NASDAQ: PGNY ): Q3 GAAP EPS of $0.13 beats by $0.08 . Revenue of $205.4M (+68.0% Y/Y) beats by $10.96M . Shares +6.6% . FY 2022 Outlook : Revenue is now projected to be $775.0 million to $785.0 million, reflecting growth of 5...

Receives Record Number of New Client Commitments in Selling Season Reports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year Period Raises Full Year 2022 Guidance, Reflecting Fourth Quarter Revenue Growth of 59% to 67% NEW YORK, Nov. 03, 2022 (GLO...

Summary Against a background of rising rates and recession risks, the Strategy outperformed its benchmark driven by our selections in the IT, industrials and health care sectors. We were active in repositioning the portfolio in the quarter as market crosswinds opened idiosyncratic...

While growth stocks often show exceptional top-line acceleration and a mere promise of profitability further down the road, some young companies have already reached that mark. That's true for Veeva Systems (NYSE: VEEV) and Progyny (NASDAQ: PGNY) . Both bring much-needed sol...